An improved LC-MS/MS method for the quantification of alverine and para hydroxy alverine in human plasma for a bioequivalence study☆

A highly sensitive and selective high performance liquid chromatography-tandem mass spectrometry method was developed and validated for the quantification of alverine (ALV) and its active metabolite, para hydroxy alverine (PHA), in human plasma. For sample preparation, solid phase extraction of anal...

Full description

Bibliographic Details
Main Authors: Dhiraj M. Rathod, Keyur R. Patel, Hiren N. Mistri, Arvind G. Jangid, Pranav S. Shrivastav, Mallika Sanyal
Format: Article
Language:English
Published: Elsevier 2017-04-01
Series:Journal of Pharmaceutical Analysis
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2095177916301228
_version_ 1818727298579300352
author Dhiraj M. Rathod
Keyur R. Patel
Hiren N. Mistri
Arvind G. Jangid
Pranav S. Shrivastav
Mallika Sanyal
author_facet Dhiraj M. Rathod
Keyur R. Patel
Hiren N. Mistri
Arvind G. Jangid
Pranav S. Shrivastav
Mallika Sanyal
author_sort Dhiraj M. Rathod
collection DOAJ
description A highly sensitive and selective high performance liquid chromatography-tandem mass spectrometry method was developed and validated for the quantification of alverine (ALV) and its active metabolite, para hydroxy alverine (PHA), in human plasma. For sample preparation, solid phase extraction of analytes was performed on Phenomenex Strata-X cartridges using alverine-d5 as the internal standard. The analytes were separated on Symmetry Shield RP18 (150 mm×3.9 mm, 5 µm) column with a mobile phase consisting of acetonitrile and 10 mM ammonium formate (65:35, v/v). Detection and quantitation was done by electrospray ionization mass spectrometry in the positive mode using multiple reaction monitoring. The assay method was fully validated over the concentration range of 15.0–15,000 pg/mL for ALV and 30.0–15,000 pg/mL for PHA. The intra-day and inter-day accuracy and precision (% CV) ranged from 94.00% to 96.00% and 0.48% to 4.15% for both the analytes. The mean recovery obtained for ALV and PHA was 80.59% and 81.26%, respectively. Matrix effect, expressed as IS-normalized matrix factor ranged from 0.982 to 1.009 for both the analytes. The application of the method was demonstrated for the specific analysis of ALV and PHA for a bioequivalence study in 52 healthy subjects using 120 mg ALV capsules. The assay reproducibility was also verified by reanalysis of 175 incurred subject samples.
first_indexed 2024-12-17T22:11:53Z
format Article
id doaj.art-ab9f7dc3edbe4ac790f752b4c71282e1
institution Directory Open Access Journal
issn 2095-1779
language English
last_indexed 2024-12-17T22:11:53Z
publishDate 2017-04-01
publisher Elsevier
record_format Article
series Journal of Pharmaceutical Analysis
spelling doaj.art-ab9f7dc3edbe4ac790f752b4c71282e12022-12-21T21:30:44ZengElsevierJournal of Pharmaceutical Analysis2095-17792017-04-01729510210.1016/j.jpha.2016.11.003An improved LC-MS/MS method for the quantification of alverine and para hydroxy alverine in human plasma for a bioequivalence study☆Dhiraj M. Rathod0Keyur R. Patel1Hiren N. Mistri2Arvind G. Jangid3Pranav S. Shrivastav4Mallika Sanyal5Department of Chemistry, Kadi Sarva Vishwavidyalaya, Gandhinagar, Ahmedabad-382015, IndiaBioanalytical Research Department, Accutest Research Lab, Bodakdev, Ahmedabad-380059, IndiaBioanalytical Research Department, Accutest Research Lab, Bodakdev, Ahmedabad-380059, IndiaBioanalytical Research Department, Accutest Research Lab, Bodakdev, Ahmedabad-380059, IndiaDepartment of Chemistry, School of Sciences, Gujarat University, Ahmedabad-380009, IndiaDepartment of Chemistry, St. Xavier's College, Navrangpura, Ahmedabad-380009, IndiaA highly sensitive and selective high performance liquid chromatography-tandem mass spectrometry method was developed and validated for the quantification of alverine (ALV) and its active metabolite, para hydroxy alverine (PHA), in human plasma. For sample preparation, solid phase extraction of analytes was performed on Phenomenex Strata-X cartridges using alverine-d5 as the internal standard. The analytes were separated on Symmetry Shield RP18 (150 mm×3.9 mm, 5 µm) column with a mobile phase consisting of acetonitrile and 10 mM ammonium formate (65:35, v/v). Detection and quantitation was done by electrospray ionization mass spectrometry in the positive mode using multiple reaction monitoring. The assay method was fully validated over the concentration range of 15.0–15,000 pg/mL for ALV and 30.0–15,000 pg/mL for PHA. The intra-day and inter-day accuracy and precision (% CV) ranged from 94.00% to 96.00% and 0.48% to 4.15% for both the analytes. The mean recovery obtained for ALV and PHA was 80.59% and 81.26%, respectively. Matrix effect, expressed as IS-normalized matrix factor ranged from 0.982 to 1.009 for both the analytes. The application of the method was demonstrated for the specific analysis of ALV and PHA for a bioequivalence study in 52 healthy subjects using 120 mg ALV capsules. The assay reproducibility was also verified by reanalysis of 175 incurred subject samples.http://www.sciencedirect.com/science/article/pii/S2095177916301228AlverinePara hydroxy alverineLiquid chromatography-tandem mass spectrometryBioequivalence studyHuman plasma
spellingShingle Dhiraj M. Rathod
Keyur R. Patel
Hiren N. Mistri
Arvind G. Jangid
Pranav S. Shrivastav
Mallika Sanyal
An improved LC-MS/MS method for the quantification of alverine and para hydroxy alverine in human plasma for a bioequivalence study☆
Journal of Pharmaceutical Analysis
Alverine
Para hydroxy alverine
Liquid chromatography-tandem mass spectrometry
Bioequivalence study
Human plasma
title An improved LC-MS/MS method for the quantification of alverine and para hydroxy alverine in human plasma for a bioequivalence study☆
title_full An improved LC-MS/MS method for the quantification of alverine and para hydroxy alverine in human plasma for a bioequivalence study☆
title_fullStr An improved LC-MS/MS method for the quantification of alverine and para hydroxy alverine in human plasma for a bioequivalence study☆
title_full_unstemmed An improved LC-MS/MS method for the quantification of alverine and para hydroxy alverine in human plasma for a bioequivalence study☆
title_short An improved LC-MS/MS method for the quantification of alverine and para hydroxy alverine in human plasma for a bioequivalence study☆
title_sort improved lc ms ms method for the quantification of alverine and para hydroxy alverine in human plasma for a bioequivalence study☆
topic Alverine
Para hydroxy alverine
Liquid chromatography-tandem mass spectrometry
Bioequivalence study
Human plasma
url http://www.sciencedirect.com/science/article/pii/S2095177916301228
work_keys_str_mv AT dhirajmrathod animprovedlcmsmsmethodforthequantificationofalverineandparahydroxyalverineinhumanplasmaforabioequivalencestudy
AT keyurrpatel animprovedlcmsmsmethodforthequantificationofalverineandparahydroxyalverineinhumanplasmaforabioequivalencestudy
AT hirennmistri animprovedlcmsmsmethodforthequantificationofalverineandparahydroxyalverineinhumanplasmaforabioequivalencestudy
AT arvindgjangid animprovedlcmsmsmethodforthequantificationofalverineandparahydroxyalverineinhumanplasmaforabioequivalencestudy
AT pranavsshrivastav animprovedlcmsmsmethodforthequantificationofalverineandparahydroxyalverineinhumanplasmaforabioequivalencestudy
AT mallikasanyal animprovedlcmsmsmethodforthequantificationofalverineandparahydroxyalverineinhumanplasmaforabioequivalencestudy
AT dhirajmrathod improvedlcmsmsmethodforthequantificationofalverineandparahydroxyalverineinhumanplasmaforabioequivalencestudy
AT keyurrpatel improvedlcmsmsmethodforthequantificationofalverineandparahydroxyalverineinhumanplasmaforabioequivalencestudy
AT hirennmistri improvedlcmsmsmethodforthequantificationofalverineandparahydroxyalverineinhumanplasmaforabioequivalencestudy
AT arvindgjangid improvedlcmsmsmethodforthequantificationofalverineandparahydroxyalverineinhumanplasmaforabioequivalencestudy
AT pranavsshrivastav improvedlcmsmsmethodforthequantificationofalverineandparahydroxyalverineinhumanplasmaforabioequivalencestudy
AT mallikasanyal improvedlcmsmsmethodforthequantificationofalverineandparahydroxyalverineinhumanplasmaforabioequivalencestudy